These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15820926)

  • 1. Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies.
    Gordeuk VR
    Haematologica; 2005 Apr; 90(4):433-4. PubMed ID: 15820926
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies.
    Derchi G; Forni GL; Formisano F; Cappellini MD; Galanello R; D'Ascola G; Bina P; Magnano C; Lamagna M
    Haematologica; 2005 Apr; 90(4):452-8. PubMed ID: 15820939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary hypertension in patients with hemoglobinopathies: could a mechanism for dysfunction provide an avenue for novel therapeutics?
    Lin EE; Gladwin MT; Machado RF
    Haematologica; 2005 Apr; 90(4):441-4. PubMed ID: 15820937
    [No Abstract]   [Full Text] [Related]  

  • 4. Sildenafil for pulmonary arterial hypertension complicating respiratory disease.
    Aggarwal AN
    Indian J Chest Dis Allied Sci; 2008; 50(4):317-9. PubMed ID: 19035049
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic approaches to pulmonary hypertension in hemoglobinopathies: Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathy.
    Derchi G; Forni GL
    Ann N Y Acad Sci; 2005; 1054():471-5. PubMed ID: 16339700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sildenafil in pulmonary hypertension].
    Ewert R; Höper M; Halank M; Winkler J; Wensel R; Opitz C
    Pneumologie; 2003 May; 57(5):291; author reply 291-2; discussion 292. PubMed ID: 12825577
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of severe portopulmonary hypertension in a patient with Child C cirrhosis by sildenafil.
    Callejas Rubio JL; Salmerón Escobar J; González-Calvín J; Ortego Centeno N
    Liver Transpl; 2006 Apr; 12(4):690-1. PubMed ID: 16555327
    [No Abstract]   [Full Text] [Related]  

  • 8. Sildenafil in neonatal pulmonary hypertension due to impaired alveolarisation and plexiform pulmonary arteriopathy.
    Chaudhari M; Vogel M; Wright C; Smith J; Haworth SG
    Arch Dis Child Fetal Neonatal Ed; 2005 Nov; 90(6):F527-8. PubMed ID: 16244212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of sildenafil in primary pulmonary hypertension.
    Oudiz RJ; Wasserman K
    J Am Coll Cardiol; 2004 Dec; 44(11):2256; author reply 2256-7. PubMed ID: 15582332
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sildenafil treatment of unilateral pulmonary edema and pulmonary hypertension in pulmonary artery agenesis].
    Rodríguez-Gómez F; Martín I; Sánchez A; Pujol E
    Rev Esp Cardiol; 2006 Dec; 59(12):1347-9. PubMed ID: 17194435
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of pulmonary arterial hypertension with sildenafil: from pathophysiology to clinical evidence.
    Raja SG; Danton MD; MacArthur KJ; Pollock JC
    J Cardiothorac Vasc Anesth; 2006 Oct; 20(5):722-35. PubMed ID: 17023298
    [No Abstract]   [Full Text] [Related]  

  • 12. [New indications for sildenafil in sight. Potency drug is potent in pulmonary hypertension].
    MMW Fortschr Med; 2004 Apr; 146(18):8. PubMed ID: 15366459
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination pharmacotherapy for severe neonatal pulmonary hypertension.
    Filan PM; McDougall PN; Shekerdemian LS
    J Paediatr Child Health; 2006 Apr; 42(4):219-20. PubMed ID: 16630327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sildenafil in older patients with secondary pulmonary hypertension.
    Minotti GC; Corsonello A; Incalzi RA
    J Am Geriatr Soc; 2007 Oct; 55(10):1681-2. PubMed ID: 17908072
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of sildenafil on pulmonary hypertension and exercise tolerance in severe cystic fibrosis-related lung disease.
    Montgomery GS; Sagel SD; Taylor AL; Abman SH
    Pediatr Pulmonol; 2006 Apr; 41(4):383-5. PubMed ID: 16479610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revatio (sildenafil citrate) for the treatment of pulmonary arterial hypertension.
    Sahni J
    Conn Med; 2006; 70(6):381-3. PubMed ID: 16869470
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of pulmonary arterial hypertension: phosphodiesterase-5 inhibitors].
    Ghofrani HA; Grimminger F
    Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S311-4. PubMed ID: 17139594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiating the pulmonary vasodilatory effects produced by sildenafil.
    Dias-Junior CA
    Respir Med; 2007 May; 101(5):1041; author reply 1042. PubMed ID: 17321734
    [No Abstract]   [Full Text] [Related]  

  • 19. The efficacy and safety of sildenafil in Chinese patients with pulmonary arterial hypertension.
    Xu XQ; Jing ZC; Zhang JH; Wu Y; Wang Y; Jiang X; Wang ZX; Sun YG; Pu JL; Yang YJ
    Hypertens Res; 2009 Oct; 32(10):911-5. PubMed ID: 19644505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
    Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
    J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.